Warning letter
Remel Inc.: warning letter of Feb 23, 1999
FDA warning letter UCM067129 · Kansas City District Office
Key facts
| Reference number | UCM067129 |
|---|---|
| Company | Remel Inc. |
| Subject | In Vitro Diagnostic Products |
| Issue date | Feb 23, 1999 |
| Posted date | Feb 23, 1999 |
| Issuing office | Kansas City District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: